Candel Therapeutics, Inc. (NASDAQ:CADL – Get Free Report) saw a significant drop in short interest in May. As of May 15th, there was short interest totalling 846,800 shares, a drop of 19.4% from the April 30th total of 1,050,000 shares. Based on an average daily trading volume, of 5,450,000 shares, the short-interest ratio is currently […]
Candel-therapeutics-inc
Nasdaq
Candel-therapeutics
Get-free-report
Candel-therapeutics-daily
Candel Therapeutics (NASDAQ: CADL) Reports Positive Data From Phase 2 Trial Of CAN-2409 In Borderline Resectable Pancreatic Cancer
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.
Candel-therapeutics-incCandel-therapeutics